Orangeburg-based Zeus names new CEO

Listen to this article

Zeus has named a new leader.

The polymer extrusion and catheter design manufacturer has named Padraic “Paddy” O’Brien as CEO, effective April 1, according to a news release.

O’Brien joins Zeus at a pivotal moment as the company enters a new chapter of growth under EQT ownership, the release stated.

“We are thrilled to welcome Paddy as the new CEO of Zeus,” said John Groetelaars, executive chairman at Zeus, in the release. “He has deep insights and a keen understanding of the interventional markets targeted by Zeus’ customers. His extensive experience and proven track record make him the ideal leader to steer Zeus through this exciting chapter of growth and advancement.”

Related content: Orangeburg medical device manufacturer Zeus acquired in $3B deal

O’Brien is currently worldwide president of BD Peripheral Intervention at Becton, Dickinson, and Co. (NYSE: BDX), a medical technology company focused on advancing clinical therapy for patients and clinical process for health care providers, according to the release.

Before that, he held various leadership positions within BD, where he developed a track record of delivering durable, sustainable growth, the release stated. From 2001-16, he held a series of ascending management positions within Bard until BD acquired the company in December 2017.

O’Brien holds a bachelor’s from Santa Clara University.

“We undertook an extensive search to find Zeus’ next CEO, and Paddy’s deep domain knowledge and experience make him perfectly suited to lead the company through this next phase of growth,” Ethan Waxman, partner within EQT Private Equity’s Advisory Team, said in the release. “We look forward to partnering with Paddy as we make significant investments in increased capacity, process improvement, and product innovation.”